News | October 12, 2025
Samsung Biologics introduces optimized manufacturing framework ‘ExellenS’
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
The new site enables end-to-end production of viral vector gene therapies
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Subscribe To Our Newsletter & Stay Updated
